FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:243-250 January 23, 1997 Number 4 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background There is considerable variability in rates of hospitalization of patients with community-acquired pneumonia, in part because of physicians' uncertainty in assessing the severity of illness at presentation.

Methods From our analysis of data on 14,199 adult inpatients with community-acquired pneumonia, we derived a prediction rule that stratifies patients into five classes with respect to the risk of death within 30 days. The rule was validated with 1991 data on 38,039 inpatients and with data on 2287 inpatients and outpatients in the Pneumonia Patient Outcomes Research Team (PORT) cohort study. The prediction rule assigns points based on age and the presence of coexisting disease, abnormal physical findings (such as a respiratory rate of >30 per minute or a temperature of >40°C), and abnormal laboratory findings (such as a pH <7.35, a blood urea nitrogen concentration >30 mg per deciliter [11 mmol per liter] or a sodium concentration <130 mmol per liter) at presentation.

Results There were no significant differences in mortality in each of the five risk classes among the three cohorts. Mortality ranged from 0.1 to 0.4 percent for class I patients (P = 0.22), from 0.6 to 0.7 percent for class II (P = 0.67), and from 0.9 to 2.8 percent for class III (P = 0.12). Among the 1575 patients in the three lowest risk classes in the Pneumonia PORT cohort, there were only seven deaths, of which only four were pneumonia-related. The risk class was significantly associated with the risk of subsequent hospitalization among those treated as outpatients and with the use of intensive care and the number of days in the hospital among inpatients.

Conclusions The prediction rule we describe accurately identifies the patients with community-acquired pneumonia who are at low risk for death and other adverse outcomes. This prediction rule may help physicians make more rational decisions about hospitalization for patients with pneumonia.

Source Information

From the Division of General Medicine, Department of Medicine (M.J.F., B.H.H., W.N.K.), the Department of Emergency Medicine (T.E.A., D.M.Y.), and the Department of Biostatistics (L.A.W.), Graduate School of Public Health, University of Pittsburgh, Pittsburgh; the General Internal Medicine Unit, Medical Services, Massachusetts General Hospital and Harvard Medical School, Boston (D.E.S., C.M.C.); and the Division of Infectious Diseases, Department of Medicine, Victoria General Hospital and Dalhousie University, Halifax, N.S., Canada (T.J.M.).

Address reprint requests to Dr. Fine at Montefiore University Hospital, 8 East Rm. 824, 200 Lothrop St., Pittsburgh, PA 15213.

Full Text of this Article

Related Letters:

A Prediction Rule for Community-Acquired Pneumonia
Bloom S. L., Ramin S., Cunningham F. G., Tsiodras S., Malhotra G., Fine M. J., Auble T. E., Hanusa B. H., Singer D. E.
Extract | Full Text  
N Engl J Med 1997; 336:1913-1915, Jun 26, 1997. Correspondence

This article has been cited by other articles:

• Baggish, A L, Lloyd-Jones, D M, Blatt, J, Richards, A M, Lainchbury, J, O'Donoghue, M, Sakhuja, R, Chen, A A, Januzzi, J L (2008). A clinical and biochemical score for mortality prediction in patients with acute dyspnoea: derivation, validation and incorporation into a bedside programme. Heart 94: 1032-1037 [Abstract] [Full Text]  
• Bont, J., Hak, E., Hoes, A. W., Macfarlane, J. T., Verheij, T. J. M. (2008). Predicting Death in Elderly Patients With Community-Acquired Pneumonia: A Prospective Validation Study Reevaluating the CRB-65 Severity Assessment Tool. Arch Intern Med 168: 1465-1468 [Full Text]  
• Kothe, H., Bauer, T., Marre, R., Suttorp, N., Welte, T., Dalhoff, K., the Competence Network for Community-Acquired Pneu, (2008). Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J 32: 139-146 [Abstract] [Full Text]  
• Calbo, E., Alsina, M., Rodriguez-Carballeira, M., Lite, J., Garau, J. (2008). Systemic Expression of Cytokine Production in Patients with Severe Pneumococcal Pneumonia: Effects of Treatment with a {beta}-Lactam versus a Fluoroquinolone. Antimicrob. Agents Chemother. 52: 2395-2402 [Abstract] [Full Text]  
• Wachter, R. M., Flanders, S. A., Fee, C., Pronovost, P. J. (2008). Public Reporting of Antibiotic Timing in Patients with Pneumonia: Lessons from a Flawed Performance Measure. ANN INTERN MED 149: 29-32 [Abstract] [Full Text]  
• Shah, S. S., DiCristina, C. M., Bell, L. M., Ten Have, T., Metlay, J. P. (2008). Primary Early Thoracoscopy and Reduction in Length of Hospital Stay and Additional Procedures Among Children With Complicated Pneumonia: Results of a Multicenter Retrospective Cohort Study. Arch Pediatr Adolesc Med 162: 675-681 [Abstract] [Full Text]  
• Durrington, H. J, Summers, C. (2008). Recent changes in the management of community acquired pneumonia in adults. BMJ 336: 1429-1433 [Full Text]  
• Gotoh, S., Nishimura, N., Takahashi, O., Shiratsuka, H., Horinouchi, H., Ono, H., Uchiyama, N., Chohnabayashi, N. (2008). Adrenal function in patients with community-acquired pneumonia. Eur Respir J 31: 1268-1273 [Abstract] [Full Text]  
• Yende, S., D'Angelo, G., Kellum, J. A., Weissfeld, L., Fine, J., Welch, R. D., Kong, L., Carter, M., Angus, D. C., for the GenIMS Investigators, (2008). Inflammatory Markers at Hospital Discharge Predict Subsequent Mortality after Pneumonia and Sepsis. Am. J. Respir. Crit. Care Med. 177: 1242-1247 [Abstract] [Full Text]  
• Reyes, S., Martinez, R., Valles, J. M., Cases, E., Menendez, R. (2008). Determinants of hospital costs in community-acquired pneumonia. Eur Respir J 31: 1061-1067 [Abstract] [Full Text]  
• Maimon, N., Nopmaneejumruslers, C., Marras, T. K. (2008). Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis. Eur Respir J 31: 1068-1076 [Abstract] [Full Text]  
• Menendez, R, Cavalcanti, M, Reyes, S, Mensa, J, Martinez, R, Marcos, M A, Filella, X, Niederman, M, Torres, A (2008). Markers of treatment failure in hospitalised community acquired pneumonia. Thorax 63: 447-452 [Abstract] [Full Text]  
• Mortensen, E. M., Pugh, M. J., Copeland, L. A., Restrepo, M. I., Cornell, J. E., Anzueto, A., Pugh, J. A. (2008). Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia. Eur Respir J 31: 611-617 [Abstract] [Full Text]  
• Weatherall, C, Paoloni, R, Gottlieb, T (2008). Point-of-care urinary pneumococcal antigen test in the emergency department for community acquired pneumonia. Emerg. Med. J. 25: 144-148 [Abstract] [Full Text]  
• Restrepo, M. I., Bienen, T., Mortensen, E. M., Anzueto, A., Metersky, M. L., Escalante, P., Wunderink, R. G., Mangura, B. T., On Behalf of the Chest Infections Network, (2008). Evaluation of ICU Admission Criteria and Diagnostic Methods for Patients With Severe Community-Acquired Pneumonia: Current Practice Survey. Chest 133: 828-829 [Full Text]  
• Restrepo, M. I., Mortensen, E. M., Velez, J. A., Frei, C., Anzueto, A. (2008). A Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU. Chest 133: 610-617 [Abstract] [Full Text]  
• Bordon, J., Peyrani, P., Brock, G. N., Blasi, F., Rello, J., File, T., Ramirez, J., for the CAPO Study Group, (2008). The Presence of Pneumococcal Bacteremia Does Not Influence Clinical Outcomes in Patients With Community-Acquired Pneumonia: Results From the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study. Chest 133: 618-624 [Abstract] [Full Text]  
• Teramoto, S., Yamamoto, H., Yamaguchi, Y., Hanaoka, Y., Ishii, M., Hibi, S., Kume, H., Ouchi, Y. (2008). Lower respiratory tract infection outcomes are predicted better by an age >80 years than by CURB-65. Eur Respir J 31: 477-478 [Full Text]  
• Charles, P. G. P., Valencia, M., Torres, A., Badia, J. (2008). Predicting Need for ICU in Community-Acquired Pneumonia. Chest 133: 587-588 [Full Text]  
• Kruger, S., Ewig, S., Marre, R., Papassotiriou, J., Richter, K., von Baum, H., Suttorp, N., Welte, T., on behalf of the CAPNETZ Study Group, (2008). Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 31: 349-355 [Abstract] [Full Text]  
• Kollef, K. E., Reichley, R. M., Micek, S. T., Kollef, M. H. (2008). The Modified APACHE II Score Outperforms Curb65 Pneumonia Severity Score as a Predictor of 30-Day Mortality in Patients With Methicillin-Resistant Staphylococcus aureus Pneumonia. Chest 133: 363-369 [Abstract] [Full Text]  
• van de Garde, E. M. W., Endeman, H., Deneer, V. H. M., Biesma, D. H., Sayed-Tabatabaei, F. A., Ruven, H. J. T., Leufkens, H. G. M., van den Bosch, J. M. M. (2008). Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Risk and Outcome of Pneumonia. Chest 133: 220-225 [Abstract] [Full Text]  
• Jennings, L C, Anderson, T P, Beynon, K A, Chua, A, Laing, R T R, Werno, A M, Young, S A, Chambers, S T, Murdoch, D R (2008). Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 63: 42-48 [Abstract] [Full Text]  
• Miyashita, N., Obase, Y., Ouchi, K., Kawasaki, K., Kawai, Y., Kobashi, Y., Oka, M. (2007). Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit. J Med Microbiol 56: 1625-1629 [Abstract] [Full Text]  
• Masia, M., Papassotiriou, J., Morgenthaler, N. G., Hernandez, I., Shum, C., Gutierrez, F. (2007). Midregional Pro-A-Type Natriuretic Peptide and Carboxy-Terminal Provasopressin May Predict Prognosis in Community-Acquired Pneumonia. Clin. Chem. 53: 2193-2201 [Abstract] [Full Text]  
• Garcia-Vidal, C., Calbo, E., Pascual, V., Ferrer, C., Quintana, S., Garau, J. (2007). Effects of systemic steroids in patients with severe community-acquired pneumonia. Eur Respir J 30: 951-956 [Abstract] [Full Text]  
• Opmeer, B. C., el Moussaoui, R., Bossuyt, P. M. M., Speelman, P., Prins, J. M., de Borgie, C. A. J. M. (2007). Costs associated with shorter duration of antibiotic therapy in hospitalized patients with mild-to-moderate severe community-acquired pneumonia. J Antimicrob Chemother 60: 1131-1136 [Abstract] [Full Text]  
• Lodise, T. P., Kwa, A., Cosler, L., Gupta, R., Smith, R. P. (2007). Comparison of {beta}-Lactam and Macrolide Combination Therapy versus Fluoroquinolone Monotherapy in Hospitalized Veterans Affairs Patients with Community-Acquired Pneumonia. Antimicrob. Agents Chemother. 51: 3977-3982 [Abstract] [Full Text]  
• Christ-Crain, M., Stolz, D., Jutla, S., Couppis, O., Muller, C., Bingisser, R., Schuetz, P., Tamm, M., Edwards, R., Muller, B., Grossman, A. B. (2007). Free and Total Cortisol Levels as Predictors of Severity and Outcome in Community-acquired Pneumonia. Am. J. Respir. Crit. Care Med. 176: 913-920 [Abstract] [Full Text]  
• Johnstone, J., Marrie, T. J., Eurich, D. T., Majumdar, S. R. (2007). Effect of Pneumococcal Vaccination in Hospitalized Adults With Community-Acquired Pneumonia. Arch Intern Med 167: 1938-1943 [Abstract] [Full Text]  
• Menendez, R., Torres, A. (2007). Treatment Failure in Community-Acquired Pneumonia. Chest 132: 1348-1355 [Abstract] [Full Text]  
• Christ-Crain, M., Muller, B. (2007). Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 30: 556-573 [Abstract] [Full Text]  
• Schaaf, B., Kruse, J., Rupp, J., Reinert, R. R., Droemann, D., Zabel, P., Ewig, S., Dalhoff, K. (2007). Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia. Eur Respir J 30: 517-524 [Abstract] [Full Text]  
• Kornum, J. B., Thomsen, R. W., Riis, A., Lervang, H.-H., Schonheyder, H. C., Sorensen, H. T. (2007). Type 2 Diabetes and Pneumonia Outcomes: A population-based cohort study. Diabetes Care 30: 2251-2257 [Abstract] [Full Text]  
• Kellum, J. A., Kong, L., Fink, M. P., Weissfeld, L. A., Yealy, D. M., Pinsky, M. R., Fine, J., Krichevsky, A., Delude, R. L., Angus, D. C., for the GenIMS Investigators, (2007). Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 167: 1655-1663 [Abstract] [Full Text]  
• Fishbane, S., Niederman, M. S., Daly, C., Magin, A., Kawabata, M., de Corla-Souza, A., Choudhery, I., Brody, G., Gaffney, M., Pollack, S., Parker, S. (2007). The Impact of Standardized Order Sets and Intensive Clinical Case Management on Outcomes in Community-Acquired Pneumonia. Arch Intern Med 167: 1664-1669 [Abstract] [Full Text]  
• Rubenstein, L. V., Rayburn, N. R., Keeler, E. B., Ford, D. E., Rost, K. M., Sherbourne, C. D. (2007). Predicting Outcomes of Primary Care Patients With Major Depression: Development of a Depression Prognosis Index. Psychiatr. Serv. 58: 1049-1056 [Abstract] [Full Text]  
• Valencia, M., Badia, J. R., Cavalcanti, M., Ferrer, M., Agusti, C., Angrill, J., Garcia, E., Mensa, J., Niederman, M. S., Torres, A. (2007). Pneumonia Severity Index Class V Patients With Community-Acquired Pneumonia: Characteristics, Outcomes, and Value of Severity Scores. Chest 132: 515-522 [Abstract] [Full Text]  
• Bont, J., Hak, E., Birkhoff, C. E, Hoes, A. W, Verheij, T. J. (2007). Is co-morbidity taken into account in the antibiotic management of elderly patients with acute bronchitis and COPD exacerbations?. Fam Pract 24: 317-322 [Abstract] [Full Text]  
• Carratala, J., Mykietiuk, A., Fernandez-Sabe, N., Suarez, C., Dorca, J., Verdaguer, R., Manresa, F., Gudiol, F. (2007). Health Care-Associated Pneumonia Requiring Hospital Admission: Epidemiology, Antibiotic Therapy, and Clinical Outcomes. Arch Intern Med 167: 1393-1399 [Abstract] [Full Text]  
• File, T. M. Jr, Mandell, L. A., Tillotson, G., Kostov, K., Georgiev, O. (2007). Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study. J Antimicrob Chemother 60: 112-120 [Abstract] [Full Text]  
• Kanwar, M., Brar, N., Khatib, R., Fakih, M. G. (2007). Misdiagnosis of Community-Acquired Pneumonia and Inappropriate Utilization of Antibiotics: Side Effects of the 4-h Antibiotic Administration Rule. Chest 131: 1865-1869 [Abstract] [Full Text]  
• Arnold, F. W., Summersgill, J. T., LaJoie, A. S., Peyrani, P., Marrie, T. J., Rossi, P., Blasi, F., Fernandez, P., File, T. M. Jr., Rello, J., Menendez, R., Marzoratti, L., Luna, C. M., Ramirez, J. A., the Community-Acquired Pneumonia Organization (CAP, (2007). A Worldwide Perspective of Atypical Pathogens in Community-acquired Pneumonia. Am. J. Respir. Crit. Care Med. 175: 1086-1093 [Abstract] [Full Text]  
• Bont, J., Hak, E., Hoes, A. W., Schipper, M., Schellevis, F. G., Verheij, T. J. M. (2007). A prediction rule for elderly primary-care patients with lower respiratory tract infections. Eur Respir J 29: 969-975 [Abstract] [Full Text]  
• Martin, M., Quilici, S., File, T., Garau, J., Kureishi, A., Kubin, M. (2007). Cost-effectiveness of empirical prescribing of antimicrobials in community-acquired pneumonia in three countries in the presence of resistance. J Antimicrob Chemother 59: 977-989 [Abstract] [Full Text]  
• Porcel, J. M., Ruiz-Gonzalez, A., Falguera, M., Nogues, A., Galindo, C., Carratala, J., Esquerda, A. (2007). Contribution of a Pleural Antigen Assay (Binax NOW) to the Diagnosis of Pneumococcal Pneumonia. Chest 131: 1442-1447 [Abstract] [Full Text]  
• Menendez, R., Reyes, S., Martinez, R., de la Cuadra, P., Manuel Valles, J., Vallterra, J. (2007). Economic evaluation of adherence to treatment guidelines in nonintensive care pneumonia. Eur Respir J 29: 751-756 [Abstract] [Full Text]  
• Bhatt, S. P. (2007). One More Prediction Rule: Has Anything New Been Added?. Am. J. Respir. Crit. Care Med. 175: 743-743 [Full Text]  
• Lim, W. S. (2007). Severity assessment in community-acquired pneumonia: moving on. Thorax 62: 287-288 [Full Text]  
• Yan Man, S., Lee, N., Ip, M., Antonio, G. E, Chau, S. S L, Mak, P., Graham, C. A, Zhang, M., Lui, G., Chan, P. K S, Ahuja, A. T, Hui, D. S, Sung, J. J Y, Rainer, T. H (2007). Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax 62: 348-353 [Abstract] [Full Text]  
• Diaz, A., Barria, P., Niederman, M., Restrepo, M. I., Dreyse, J., Fuentes, G., Couble, B., Saldias, F. (2007). Etiology of Community-Acquired Pneumonia in Hospitalized Patients in Chile: The Increasing Prevalence of Respiratory Viruses Among Classic Pathogens. Chest 131: 779-787 [Abstract] [Full Text]  
• Barlow, G., Nathwani, D., Davey, P. (2007). The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia. Thorax 62: 253-259 [Abstract] [Full Text]  
• Labarere, J., Stone, R. A., Obrosky, D. S., Yealy, D. M., Meehan, T. P., Fine, J. M., Graff, L. G., Fine, M. J. (2007). Comparison of Outcomes for Low-Risk Outpatients and Inpatients With Pneumonia: A Propensity-Adjusted Analysis. Chest 131: 480-488 [Abstract] [Full Text]  
• Spaude, K. A., Abrutyn, E., Kirchner, C., Kim, A., Daley, J., Fisman, D. N. (2007). Influenza Vaccination and Risk of Mortality Among Adults Hospitalized With Community-Acquired Pneumonia. Arch Intern Med 167: 53-59 [Abstract] [Full Text]  
• Niewoehner, D. E., Lokhnygina, Y., Rice, K., Kuschner, W. G., Sharafkhaneh, A., Sarosi, G. A., Krumpe, P., Pieper, K., Kesten, S. (2007). Risk Indexes for Exacerbations and Hospitalizations Due to COPD. Chest 131: 20-28 [Abstract] [Full Text]  
• Sopena, N., Force, L., Pedro-Botet, M. L., Barrufet, P., Sauca, G., Garcia-Nunez, M., Tolchinsky, G., Capdevila, J. A., Sabria, M. (2007). Sporadic and epidemic community legionellosis: two faces of the same illness. Eur Respir J 29: 138-142 [Abstract] [Full Text]  
• Oosterheert, J. J., Bonten, M. J M, Schneider, M. M E, Buskens, E., Lammers, J.-W. J, Hustinx, W. M N, Kramer, M. H H, Prins, J. M, Slee, P. H T. J, Kaasjager, K., Hoepelman, A. I M (2006). Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. BMJ 333: 1193-1193 [Abstract] [Full Text]  
• Huang, D. T., Yealy, D. M. (2006). Decision Rules and Pneumonia: What Are We "Predicting," and for Whom?. Am. J. Respir. Crit. Care Med. 174: 1169-1170 [Full Text]  
• Espana, P. P., Capelastegui, A., Gorordo, I., Esteban, C., Oribe, M., Ortega, M., Bilbao, A., Quintana, J. M. (2006). Development and Validation of a Clinical Prediction Rule for Severe Community-acquired Pneumonia. Am. J. Respir. Crit. Care Med. 174: 1249-1256 [Abstract] [Full Text]  
• Charles, P G P, Johnson, P D R, Grayson, M L, Buising, K L (2006). Still awaiting a useful tool for predicting severe CAP.. Thorax 61: 1098-1099 [Full Text]  
• Mortensen, E. M, Restrepo, M. I, Copeland, L. A, Pugh, M. J. V, Anzueto, A. (2006). Statins and outcomes in patients with pneumonia: Not only healthy user bias. BMJ 333: 1123-1124 [Full Text]  
• Majumdar, S. R, McAlister, F. A, Eurich, D. T, Padwal, R. S, Marrie, T. J (2006). Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 333: 999-999 [Abstract] [Full Text]  
• Rubin, M. A., Bateman, K., Donnelly, S., Stoddard, G. J., Stevenson, K., Gardner, R. M., Samore, M. H. (2006). Use of a Personal Digital Assistant for Managing Antibiotic Prescribing for Outpatient Respiratory Tract Infections in Rural Communities. J. Am. Med. Inform. Assoc. 13: 627-634 [Abstract] [Full Text]  
• Phua, J., Koay, E. S. C., Zhang, D., Tai, L. K., Boo, X. L., Lim, K. C., Lim, T. K. (2006). Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections. Eur Respir J 28: 695-702 [Abstract] [Full Text]  
• el Moussaoui, R., Opmeer, B. C., de Borgie, C. A.J.M., Nieuwkerk, P., Bossuyt, P. M.M., Speelman, P., Prins, J. M. (2006). Long-term Symptom Recovery and Health-Related Quality of Life in Patients With Mild-to-Moderate-Severe Community-Acquired Pneumonia.. Chest 130: 1165-1172 [Abstract] [Full Text]  
• Sun, H. K., Nicolau, D. P., Kuti, J. L. (2006). Resource Utilization of Adults Admitted to a Large Urban Hospital With Community-Acquired Pneumonia Caused by Streptococcus pneumoniae.. Chest 130: 807-814 [Abstract] [Full Text]  
• Waikar, S. S., Bonventre, J. V. (2006). Can We Rely on Blood Urea Nitrogen as a Biomarker to Determine When to Initiate Dialysis?. CJASN 1: 903-904 [Full Text]  
• Torres, A., Menendez, R. (2006). Mortality in COPD patients with community-acquired pneumonia: who is the third partner?. Eur Respir J 28: 262-263 [Full Text]  
• Restrepo, M. I., Mortensen, E. M., Pugh, J. A., Anzueto, A. (2006). COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J 28: 346-351 [Abstract] [Full Text]  
• Cowling, B. J., Muller, M. P., Wong, I. O. L., Ho, L.-M., Lo, S.-V., Tsang, T., Lam, T. H., Louie, M., Leung, G. M. (2006). Clinical prognostic rules for severe acute respiratory syndrome in low- and high-resource settings.. Arch Intern Med 166: 1505-1511 [Abstract] [Full Text]  
• Houck, P. M. (2006). Antibiotics and pneumonia: is timing everything or just a cause of more problems?. Chest 130: 1-3 [Full Text]  
• Waterer, G. W., Kessler, L. A., Wunderink, R. G. (2006). Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia.. Chest 130: 11-15 [Abstract] [Full Text]  
• Shorr, A. F., Bodi, M., Rodriguez, A., Sole-Violan, J., Garnacho-Montero, J., Rello, J., for the CAPUCI Study Investigators, (2006). Impact of antibiotic guideline compliance on duration of mechanical ventilation in critically ill patients with community-acquired pneumonia.. Chest 130: 93-100 [Abstract] [Full Text]  
• Christ-Crain, M., Stolz, D., Bingisser, R., Muller, C., Miedinger, D., Huber, P. R., Zimmerli, W., Harbarth, S., Tamm, M., Muller, B. (2006). Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia: A Randomized Trial. Am. J. Respir. Crit. Care Med. 174: 84-93 [Abstract] [Full Text]  
• el Moussaoui, R., de Borgie, C. A J M, van den Broek, P., Hustinx, W. N, Bresser, P., van den Berk, G. E L, Poley, J.-W., van den Berg, B., Krouwels, F. H, Bonten, M. J M, Weenink, C., Bossuyt, P. M M, Speelman, P., Opmeer, B. C, Prins, J. M (2006). Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.. BMJ 332: 1355-1355 [Abstract] [Full Text]  
• Rello, J., Rodriguez, A., Torres, A., Roig, J., Sole-Violan, J., Garnacho-Montero, J., de la Torre, M. V., Sirvent, J. M., Bodi, M., for the CAPUCI study investigators, (2006). Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J 27: 1210-1216 [Abstract] [Full Text]  
• Drew, R. H., Kawamoto, K., Adams, M. B. (2006). Information technology for optimizing the management of infectious diseases. Am J Health Syst Pharm 63: 957-965 [Full Text]  
• Hoare, Z., Lim, W. S. (2006). Pneumonia: update on diagnosis and management.. BMJ 332: 1077-1079 [Full Text]  
• Myint, P. K., Kamath, A. V., Vowler, S. L., Maisey, D. N., Harrison, B. D. W. (2006). Severity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts.. Age Ageing 35: 286-291 [Abstract] [Full Text]  
• Vestbo, J. (2006). Clinical Assessment, Staging, and Epidemiology of Chronic Obstructive Pulmonary Disease Exacerbations. Proc Am Thorac Soc 3: 252-256 [Abstract] [Full Text]  
• de Roux, A., Cavalcanti, M., Marcos, M. A., Garcia, E., Ewig, S., Mensa, J., Torres, A. (2006). Impact of Alcohol Abuse in the Etiology and Severity of Community-Acquired Pneumonia. Chest 129: 1219-1225 [Abstract] [Full Text]  
• Aspa, J., Rajas, O., Rodriguez de Castro, F., Huertas, M. C., Borderias, L., Cabello, F. J., Tabara, J., Hernandez-Flix, S., Martinez-Sanchis, A., Torres, A. (2006). Impact of initial antibiotic choice on mortality from pneumococcal pneumonia. Eur Respir J 27: 1010-1019 [Abstract] [Full Text]  
• Buising, K L, Thursky, K A, Black, J F, MacGregor, L, Street, A C, Kennedy, M P, Brown, G V (2006). A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax 61: 419-424 [Abstract] [Full Text]  
• de Roux, A., Ewig, S., Garcia, E., Marcos, M. A., Mensa, J., Lode, H., Torres, A. (2006). Mixed community-acquired pneumonia in hospitalised patients.. Eur Respir J 27: 795-800 [Abstract] [Full Text]  
• Dean, N. C., Sperry, P., Wikler, M., Suchyta, M. S., Hadlock, C. (2006). Comparing gatifloxacin and clarithromycin in pneumonia symptom resolution and process of care.. Antimicrob. Agents Chemother. 50: 1164-1169 [Abstract] [Full Text]  
• Dremsizov, T., Clermont, G., Kellum, J. A., Kalassian, K. G., Fine, M. J., Angus, D. C. (2006). Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course?. Chest 129: 968-978 [Abstract] [Full Text]  
• Siquier, B., Sanchez-Alvarez, J., Garcia-Mendez, E., Sabria, M., Santos, J., Pallares, R., Twynholm, M., Dal-Re, R., on behalf of the 620 Clinical Study Group, (2006). Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother 57: 536-545 [Abstract] [Full Text]  
• Berner, E. S., Houston, T. K., Ray, M. N., Allison, J. J., Heudebert, G. R., Chatham, W. W., Kennedy, J. I. Jr., Glandon, G. L., Norton, P. A., Crawford, M. A., Maisiak, R. S. (2006). Improving Ambulatory Prescribing Safety with a Handheld Decision Support System: A Randomized Controlled Trial. J. Am. Med. Inform. Assoc. 13: 171-179 [Abstract] [Full Text]  
• Lindenauer, P. K., Behal, R., Murray, C. K., Nsa, W., Houck, P. M., Bratzler, D. W. (2006). Volume, quality of care, and outcome in pneumonia.. ANN INTERN MED 144: 262-269 [Abstract] [Full Text]  
• Aujesky, D., Roy, P.-M., Le Manach, C. P., Verschuren, F., Meyer, G., Obrosky, D. S., Stone, R. A., Cornuz, J., Fine, M. J. (2006). Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J 27: 476-481 [Abstract] [Full Text]  
• Gorton, C. P., Jones, J. L. (2006). Wide Geographic Variation Between Pennsylvania Counties in the Population Rates of Hospital Admissions for Pneumonia Among Children With and Without Comorbid Chronic Conditions. Pediatrics 117: 176-180 [Abstract] [Full Text]  
• Aujesky, D., Obrosky, D. S., Stone, R. A., Auble, T. E., Perrier, A., Cornuz, J., Roy, P.-M., Fine, M. J. (2006). A Prediction Rule to Identify Low-Risk Patients With Pulmonary Embolism. Arch Intern Med 166: 169-175 [Abstract] [Full Text]  
• Ewig, S., Torres, A., Woodhead, M. (2006). Assessment of pneumonia severity: a European perspective. Eur Respir J 27: 6-8 [Full Text]